Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally

被引：6
|
作者：
Behr, Juergen [1 ]
机构：
[1] Univ Hosp LMU, Dept Med 5, German Ctr Lung Res DZL, Munich, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 02期
关键词：
SILDENAFIL; FIBROSIS; ILOPROST;
D O I：
10.1164/rccm.202110-2444ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：144 / 146
页数：4
相关论文
共 50 条
  • [21] Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Engel, Peter
    Bajwa, Abubakr
    Ravichandran, Ashwin
    Feldman, Jeremy
    Case, Amy Hajari
    Argula, Rahul G.
    Tapson, Victor
    Smith, Peter
    Deng, Chunqin
    Shen, Eric
    Nathan, Steven D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)
  • [22] Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study
    Weatherald, Jason
    Nathan, Steven D.
    El-Kersh, Karim
    Argula, Rahul G.
    DuBrock, Hilary M.
    Rischard, Franz P.
    Cassady, Steven J.
    Tarver, James
    Levine, Deborah J.
    Tapson, Victor F.
    Deng, Chunqin
    Shen, Eric
    Das, Manisit
    Waxman, Aaron B.
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [23] USE OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION AND COPD
    Al-Bedour, Arwa
    Guice, Kenneth C.
    Sheikh, Muhammad M.
    [J]. CHEST, 2022, 162 (04) : 2411A - 2411A
  • [24] Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension
    Poms, Abby
    Kingman, Martha
    [J]. CRITICAL CARE NURSE, 2011, 31 (06) : E1 - E11
  • [25] Inhaled Treprostinil in Group 3 Pulmonary Hypertension
    Saggar, Rajan
    Abtin, Fereidoun
    Channick, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1870 - 1870
  • [26] Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
    Nathan, Steven D.
    Waxman, Aaron
    Rajagopal, Sudarshan
    Case, Amy
    Johri, Shilpa
    DuBrock, Hilary
    De La Zerda, David J.
    Sahay, Sandeep
    King, Christopher
    Melendres-Groves, Lana
    Smith, Peter
    Shen, Eric
    Edwards, Lisa D.
    Nelsen, Andrew
    Tapson, Victor F.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : 1266 - 1274
  • [27] Inhaled Treprostinil In Pediatric Pulmonary Arterial Hypertension
    Rosenzweig, E. B.
    Krishnan, U.
    Takatsuki, S.
    Kerstein, J.
    Calderbank, M.
    Ivy, D. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [28] Inhaled treprostinil for the treatment of pulmonary arterial hypertension
    LeVarge, Barbara L.
    Channick, Richard N.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 255 - 265
  • [29] The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
    Bajwa, Abubakr A.
    Shujaat, Adil
    Patel, Minal
    Thomas, Colleen
    Rahaghi, Franck
    Burger, Charles D.
    [J]. PULMONARY CIRCULATION, 2017, 7 (01) : 82 - 88
  • [30] Inhaled treprostinil is a potent pulmonary vasodilator in severe pulmonary hypertension
    Voswinckel, R
    Kohstall, MG
    Enke, B
    Gessler, T
    Reichenberger, F
    Ghofrani, HA
    Seeger, W
    Olschewski, H
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 22 - 22
12345